Advanced search
Publication Cover
Scandinavian Journal of Gastroenterology Volume 52, 2017 - Issue 3
Submit an article Journal homepage
340
Views
18
CrossRef citations to date
0
Altmetric
Original Article

The role of a defunctioning stoma for colonic and perianal Crohn’s disease in the biological era

M. Martí-GallostraUnit of Colorectal Surgery, Department of General Surgery, Hospital Universitari Vall Hebrón, Barcelona, Spain; ;Unit of Colorectal Surgery, Department of Surgery, Oxford University Hospitals, Oxford, UK;
,
P. MyrelidUnit of Colorectal Surgery, Department of Surgery, Oxford University Hospitals, Oxford, UK; ;Division of Surgery, Department of Clinical and Experimental Medicine, Faculty of Health Sciences, Linköping University, Linköping, Sweden; ;Department of Surgery, County Council of Östergötland, Linköping, Sweden;
,
N. MortensenUnit of Colorectal Surgery, Department of Surgery, Oxford University Hospitals, Oxford, UK;
,
S. KeshavTranslational Gastroenterology Unit, Oxford University Hospitals, Oxford, UK
,
S. P. L. TravisTranslational Gastroenterology Unit, Oxford University Hospitals, Oxford, UK
&
B. GeorgeUnit of Colorectal Surgery, Department of Surgery, Oxford University Hospitals, Oxford, UK; Correspondence[email protected]
Pages 251-256 | Received 18 Mar 2016, Accepted 16 Jun 2016, Published online: 18 Nov 2016

References

  • Byrne CM, Solomon MJ, Young JM, et al. Patient preferences between surgical and medical treatment in Crohn's disease. Dis Colon Rectum. 2007;50:586–597.
  • Williams JG, Rothenberger DA, Nemer FD, et al. Fistula-in-ano in Crohn's disease. Results of aggressive surgical treatment. Dis Colon Rectum. 1991;34:378–384.
  • Scott HJ, Northover JM. Evaluation of surgery for perianal Crohn's fistulas. Dis Colon Rectum. 1996;39:1039–1043.
  • Makowiec F, Jehle EC, Becker HD, et al. Clinical course after transanal advancement flap repair of perianal fistula in patients with Crohn's disease. Br J Surg. 1995;82:603–606.
  • Present DH, Rutgeerts P, Targan S, et al. Infliximab for the treatment of fistulas in patients with Crohn's disease. N Engl J Med. 1999;340:1398–1405.
  • Colombel JF, Schwartz DA, Sandborn WJ, et al. Adalimumab for the treatment of fistulas in patients with Crohn's disease. Gut. 2009;58:940–948.
  • Van Assche G, Dignass A, Reinisch W, et al. The second European evidence-based Consensus on the diagnosis and management of Crohn's disease: special situations. J Crohns Colitis. 2010;4:63–101.
  • Hyder SA, Travis SP, Jewell DP, et al. Fistulating anal Crohn's disease: results of combined surgical and infliximab treatment. Dis Colon Rectum. 2006;49:1837–1841.
  • Duff S, Sagar PM, Rao M, et al. Infliximab and surgical treatment of complex anal Crohn's disease. Colorectal Dis. 2012;14:972–976.
  • Topstad DR, Panaccione R, Heine JA, et al. Combined seton placement, infliximab infusion, and maintenance immunosuppressives improve healing rate in fistulizing anorectal Crohn's disease: a single center experience. Dis Colon Rectum. 2003;46:577–583.
  • Regueiro M, Mardini H. Treatment of perianal fistulizing Crohn's disease with infliximab alone or as an adjunct to exam under anesthesia with seton placement. Inflamm Bowel Dis. 2003;9:98–103.
  • Grant DR, Cohen Z, McLeod RS. Loop ileostomy for anorectal Crohn's disease. Can J Surg. 1986;29:32–35.
  • Yamamoto T, Allan RN, Keighley MR. Effect of fecal diversion alone on perianal Crohn's disease. World J Surg. 2000;24:1258–1262. discussion 1262-1253.
  • Edwards CM, George BD, Jewell DP, et al. Role of a defunctioning stoma in the management of large bowel Crohn's disease. Br J Surg. 2000;87:1063–1066.
  • Behm BW, Bickston SJ. Tumor necrosis factor-alpha antibody for maintenance of remission in Crohn's disease. Cochrane Database Syst Rev. 2008;CD006893.
  • Zelas P, Jagelman DG. Loop illeostomy in the management of Crohn's colitis in the debilitated patient. Ann Surg. 1980;191:164–168.
  • Lichtenstein GR, Yan S, Bala M, et al. Infliximab maintenance treatment reduces hospitalizations, surgeries, and procedures in fistulizing Crohn's disease. Gastroenterology. 2005;128:862–869.
  • Sands BE, Anderson FH, Bernstein CN, et al. Infliximab maintenance therapy for fistulizing Crohn's disease. N Engl J Med. 2004;350:876–885.
  • Sands BE, Blank MA, Patel K, et al. Long-term treatment of rectovaginal fistulas in Crohn's disease: response to infliximab in the ACCENT II Study. Clin Gastroenterol Hepatol. 2004;2:912–920.
  • Hong MK, Craig Lynch A, Bell S, et al. Faecal diversion in the management of perianal Crohn's disease. Colorectal Dis. 2011;13:171–176.
  • Coscia M, Gentilini L, Laureti S, et al. Risk of permanent stoma in extensive Crohn's colitis: the impact of biological drugs. Colorectal Dis. 2013;15:1115–1122.
  • Spivak J, Landers CJ, Vasiliauskas EA, et al. Antibodies to I2 predict clinical response to fecal diversion in Crohn's disease. Inflamm Bowel Dis. 2006;12:1122–1130.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.